|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Nonselective betablocker therapy decreases intestinal permeability and serum levels of LBP and IL-6 in patients with cirrhosis显示文摘 | T. Reiberger A. Ferlitsch B.A. Payer M. Mandorfer B.B. Heinisch H. Hayden F. Lammert M. Trauner M. Peck-Radosavljevic H. Vogelsang | 2012 | Journal of Hepatology2012，，： | 5 |
| 2 | Inflammatory Bowel Disease Is a Risk Factor for Recurrent Venous Thromboembolism显示文摘 | Gottfried Novacek Ansgar Weltermann Anna Sobala Herbert Tilg Wolfgang Petritsch Walter Reinisch Andreas Mayer Thomas Haas Arthur Kaser Thomas Feichtenschlager Harry Fuchssteiner Peter Knoflach Harald Vogelsang Wolfgang Miehsler Reingard Platzer Wolfgang T | 2010 | Gastroenterology2010，，3： | 4 |
| 3 | Pharmacological- and non-pharmacological therapeutic approaches in inflammatory bowel disease in adults显示文摘Inflammatory bowel diseases(IBDs) are a group of chronic inflammatory conditions mainly of the colon and small intestine. Crohn's disease(CD) and ulcerative colitis(UC) are the most frequent types of IBD. IBD is a complex disease which arises as a result of the interaction of environmental, genetic and immunological factors. It is increasingly thought that alterations of immunological reactions of the patients to their own enterable bacteria(microfilm) may contribute to inflammation. It is characterized by mucosal and sub mucosal inflammation, perpetuated by infiltration of activated leukocytes. CD may affect the whole gastrointestinal tract while UC only attacks the large intestine. The therapeutic goal is to achieve a steroidfree long lasting remission in both entities. UC has the possibility to be cured by a total colectomy, while CD never can be cured by any operation. A lifelong intake of drugs is mostly necessary and essential. Medical treatment of IBD has to be individualized to each patient and usually starts with anti-inflammatory drugs. The choice what kind of drugs and what route administered(oral, rectal, intravenous) depends on factors including the type, the localization, and severity of the patient's disease. IBD may require immune-suppression to control symptoms such as prednisolone, thiopurines, calcineurin or sometimes folic acid inhibitors or biologics like TNF-α inhibitors or anti-integrin antibodies. For both types of disease(CD, UC) the same drugs are available but they differ in their preference in efficacy between CD and UC as 5-aminosalicylic acid for UC or budesonide for ileocecal CD. As therapeutic alternative the main mediators of the disease, namely the activated pro-inflammatory cytokine producing leukocytes can be selectively removed via two apheresis systems(Adacolumn and Cellsorba) in steroid-refractory or dependent cases. Extracorporeal photopheresis results in an increase of regulatory B cells, regulatory CD8^+ T cells and T-regs Type 1. Both types of apheresis were able to induce clinical remission and mucosal healing accompanied by tapering of steroids. | Gerda C Leitner Harald Vogelsang | 2016 | World Journal of Gastrointestinal Pharmacology and Therapeutics2016，7，1： | 3 |
| 4 | Clinical presentation of venous thromboembolism in inflammatory bowel disease显示文摘 | Pavol Papay Wolfgang Miehsler Herbert Tilg Wolfgang Petritsch Walter Reinisch Andreas Mayer Thomas Haas Arthur Kaser Thomas Feichtenschlager Harry Fuchssteiner Peter Knoflach Harald Vogelsang Reingard Platzer Wolfgang Tillinger Bernhard Jaritz Alfons Schm | 2012 | Journal of Crohn’s and Colitis2012，，： | 2 |
| 5 | Incentive Regulation and Competition in Public Utility Markets: A 20-year Perspective 显示文摘 | Ingo Vogelsang | 2002 | Journal of Regulation Economics2002，，： | 2 |
| 6 | Tissue factor exposing microparticles in inflammatory bowel disease显示文摘 | Julia Palkovits Gottfried Novacek Marietta Kollars Gregor Hron Wolf Osterode Peter Quehenberger Paul Alexander Kyrle Harald Vogelsang Walter Reinisch Pavol Papay Ansgar Weltermann | 2012 | Journal of Crohn’s and Colitis2012，，： | 2 |
| 7 | The histopathology of coeliac disease: time for a standardized report scheme for pathologists显示文摘 | Georg Oberhuber Gerhard Granditsch Harald Vogelsang | 1999 | European Journal of Gastroenterology & Hepatology1999，，： | 2 |
| 8 | Outcome Prediction by Traditional and New Markers of Inflammation in Patients with Sepsis显示文摘 | Mathias Oberhoffer Heinz Vogelsang Stefan Ru?wurm Thomas Hartung Konrad Reinhart | 1999 | Clinical Chemistry and Laboratory Medicine1999，，： | 2 |
| 9 | Testing for a Unit Root in a Time Series with a Changing Mean: Corrections and Extensions显示文摘 | PERRON P VOGELSANG T J | 1992 | Journal of Business and Economic Statistics1992，，10： | 1 |
| 10 | Quality of service provision in electric power distribution systems through reliability insurance显示文摘 | Fumagalli E Black J W Vogelsang I | 2004 | IEEE Trans on Power Systems2004，19，3： | 1 |
| 11 | Transplanted bone marrow generates new neurons in human brains显示文摘 | Mezey E Key S Vogelsang G | 2003 | Proc Natl Aead Sci USA2003，100，： | 1 |
| 12 | A systematic approach to hepatic complications in hematopoietic stem cell transplantation显示文摘 | ARAI S LEE LA VOGELSANG GB | 2002 | Journal of Hematotherapy and Stem Cell Research2002，11，： | 1 |
| 13 | Nonmyeloablative bone marrow transplantation from partially HLA-mismatched related donors using posttransplantation cyclophosphamide显示文摘 | P.V O'Donnell L Luznik R.J Jones G.B Vogelsang M.S Leffell M Phelps P Rhubart K Cowan S Piantadosi E.J Fuchs | 2002 | Biology of Blood and Marrow Transplantation2002，，7： | 1 |
| 14 | Photoluminescence from Quantum Dots in Cubic GaN/InGaN/GaN Double Hetero structures显示文摘 | HUSBERG O KHARTCHENKO A AS D J VOGELSANG H | | 0，，01： | 1 |
| 15 | Colonic spread and serum pharmacokinetics of budesonide foam in patients with mildly to moderately active ulcerative colitis显示文摘 | Brunner M Vogelsang H Greinwald R | 2005 | Aliment Pharmacol Ther2005，22，5： | 1 |
| 16 | Predictive factors for decompres- sive hemicraniectomy in malignant middle cerebral arteryinfarction 显示文摘 | Von Olnhausen O Thor6n M von Vogelsang AC | 2016 | Acta Neurochir (Wien)2016，29，： | 1 |
| 17 | Outcome prediction by traditional and new marks of inflammationm patient with sepsis 显示文摘 | Oberhoffer M Vogelsang H Russwurm S | 1999 | J clinchem Lab Med1999，37，3： | 1 |
| 18 | Degradation of short-chain alkyl-and alkanolamines by TiO2-and Pt/TiO2-assisted photocatalysis 显示文摘 | KLARE M SCHEEN J VOGELSANG K | 2000 | Chemosphere2000，41，： | 1 |
| 19 | Outcome prediction by traditional and new marks of in flammation inpatients with sepsis 显示文摘 | Oberhoffer M Vogelsang H Russwurm S | 1999 | Clin Chem Lab Med1999，37，3： | 1 |
| 20 | An in situ HVEM study of dislocation generation at Al/SiC interfaces in metal matrix composites显示文摘 | VOGELSANG M ARSENAULT R J FISHER R M | 1986 | Metall Trans A1986，17，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员